Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
A Mutation-Independent CRISPR/Cas9-based 'Knockout...
Conference

A Mutation-Independent CRISPR/Cas9-based 'Knockout and Replace' Strategy to Treat Rhodopsin-Associated Autosomal Dominant Retinitis Pigmentosa

Authors

Liu CH; Wolf P; Dong R; Huang Y; Tabbaa D; Marco E; Duke B; Pinilla A; Pant A; D'Souza R

Volume

33

Pagination

pp. A16-A16

Publisher

MARY ANN LIEBERT, INC

Publication Date

December 1, 2022

Name of conference

29th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy (ESCGT)

Conference place

SCOTLAND, Edinburgh

Conference start date

October 11, 2022

Conference end date

October 14, 2022

Conference proceedings

HUMAN GENE THERAPY

Issue

23-24

ISSN

1043-0342

Labels

Fields of Research (FoR)